AVITA Medical Sets FY26 Revenue Outlook of $80-$85mln, Secures Up to $60mln Credit Facility

AVITA Medical reports Q4 2025 net revenues of $17.6 million and FY 2025 revenues of $71.6 million, an 11% increase YoY. The company has refinanced its debt, securing up to $60 million under a new credit facility with Perceptive Advisors. AVITA Medical expects FY 2026 revenue to be between $80 and $85 million, representing a 12% to 19% increase compared to 2025. The company is also advancing its clinical pipeline with the Cohealyx-I and PermeaDerm-I studies.